Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid

Dae‐Kyun Ro; Mario Ouellet; Eric M. Paradise; Helcio Burd; Diana G. Eng; Christopher J. Paddon; Jack D. Newman; Jay D Keasling

doi:10.1186/1472-6750-8-83

Back

Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid

Article 2008 en

Related publications

Article2006

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

Dae‐Kyun Ro, Eric M. Paradise, Mario Ouellet, Karl J. Fisher, Karyn L. Newman, John M. Ndungu, Kimberly A. Ho, Rachel A. Eachus, Timothy S. Ham, James Kirby, Michelle C. Y. Chang, Sydnor T. Withers, Yoichiro Shiba, Richmond Sarpong, Jay D Keasling

Article2009

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

Sir Nicholas White, Wirichada Pongtavornpinyo, Richard J. Maude, Sompob Saralamba, Ricardo Águas, Kasia Stepniewska, Sue J. Lee, Arjen M. Dondorp, Lisa J. White, Nicholas Day

Malaria Journal

Article2013

Application of targeted proteomics and biological parts assembly in E. coli to optimize the biosynthesis of an anti-malarial drug precursor, amorpha-4,11-diene

Han Min Woo, Gregory Murray, Tanveer S. Batth, Nilu Prasad, Paul D. Adams, Jay D Keasling, Christopher J. Petzold, Taek Soon Lee

Article2011

Metabolic engineering of E.coli for the production of a precursor to artemisinin, an anti-malarial drug [Chapter 25 in Manual of Industrial Microbiology and Biotechnology, 3rd edition]

Christopher J. Petzold, Jay D Keasling

Article2008

Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene

Jennifer R. Anthony, Larry C. Anthony, Farnaz Nowroozi, Gina Kwon, Jack D. Newman, Jay D Keasling

Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid

Discussion(0)

Related publications

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

Application of targeted proteomics and biological parts assembly in E. coli to optimize the biosynthesis of an anti-malarial drug precursor, amorpha-4,11-diene

Metabolic engineering of E.coli for the production of a precursor to artemisinin, an anti-malarial drug [Chapter 25 in Manual of Industrial Microbiology and Biotechnology, 3rd edition]

Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene